Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Bone Cancer”

1,529 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,529 results

Not applicableStudy completedNCT00858585
What this trial is testing

Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 149
Testing effectiveness (Phase 2)Study completedNCT00053287
What this trial is testing

Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 42
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Not applicableStudy completedNCT03188926
What this trial is testing

Surgical Treatment of Long Bone Metastases

Who this might be right for
Bone MetastasesSurgery
Istituto Ortopedico Rizzoli 120
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Post-approval studies (Phase 4)Ended earlyNCT00819832
What this trial is testing

Anderson Circulating Tumor Cell Burden (CTCB) Study

Who this might be right for
CancerSpinal DiseaseVertebral Compression Fractures
M.D. Anderson Cancer Center 3
Not applicableUnknownNCT03814811
What this trial is testing

Circulating Osteocalcin-positive Cells in Breast Cancer Bone Metastasis

Who this might be right for
Breast NeoplasmsBone Metastases
Seoul National University Hospital 200
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Early research (Phase 1)UnknownNCT03487055
What this trial is testing

Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases

Who this might be right for
Breast Cancer
Jiangsu T-Mab Biopharma Co.,Ltd 30
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Early research (Phase 1)Study completedNCT01174888
What this trial is testing

Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia FollowingMyelodysplastic Syndrome+8 more
Alison Walker 34
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Early research (Phase 1)Study completedNCT00376480
What this trial is testing

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT00070135
What this trial is testing

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Alliance for Clinical Trials in Oncology 121
Not applicableNot Yet RecruitingNCT06910618
What this trial is testing

Prospective Observational Study on Vertebral Fracture Risk Stratification in Patients With Vertebral Metastases

Who this might be right for
Vertebral MetastasesVertebral Fracture
Buda Health Center 300
Not applicableLooking for participantsNCT06806462
What this trial is testing

Biomolecular Markers of Bone Metastasis

Who this might be right for
Bone Metastasis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 160
Large-scale testing (Phase 3)Study completedNCT02426697
What this trial is testing

Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy

Who this might be right for
Bone Metastasis
Centre Henri Becquerel 39
Testing effectiveness (Phase 2)Study completedNCT01833520
What this trial is testing

Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma

Who this might be right for
Sarcoma
M.D. Anderson Cancer Center 18
Not applicableStudy completedNCT00824213
What this trial is testing

Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer

Who this might be right for
Bone Metastases
University of British Columbia 50
Load More Results